HEADER TRANSFERASE 31-MAR-14 4PZV TITLE CRYSTAL STRUCTURE OF FRANCISELLA TULARENSIS HPPK-DHPS IN COMPLEX WITH TITLE 2 BISUBSTRATE ANALOG HPPK INHIBITOR J1D COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2-AMINO-4-HYDROXY-6-HYDROXYMETHYLDIHYDROPTERIDINE COMPND 3 PYROPHOSPHOKINASE/DIHYDROPTEROATE SYNTHASE; COMPND 4 CHAIN: A; COMPND 5 EC: 2.5.1.15, 2.7.6.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FRANCISELLA TULARENSIS SUBSP. TULARENSIS; SOURCE 3 ORGANISM_TAXID: 177416; SOURCE 4 STRAIN: SCHU S4 / SCHU 4; SOURCE 5 GENE: FOIK, FOLK, FTT_0942C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS(DE3)-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDN2163 KEYWDS FERREDOXIN-LIKE FOLD; TIM BARREL FOLD, TRANSFERASE, ATP BINDING, KEYWDS 2 PHOSPHORYLATION EXPDTA X-RAY DIFFRACTION AUTHOR G.X.SHAW,G.SHI,X.JI REVDAT 4 20-SEP-23 4PZV 1 REMARK REVDAT 3 30-AUG-23 4PZV 1 AUTHOR JRNL REMARK REVDAT 2 01-OCT-14 4PZV 1 JRNL REVDAT 1 16-JUL-14 4PZV 0 JRNL AUTH G.X.SHAW,Y.LI,G.SHI,Y.WU,S.CHERRY,D.NEEDLE,D.ZHANG, JRNL AUTH 2 J.E.TROPEA,D.S.WAUGH,H.YAN,X.JI JRNL TITL STRUCTURAL ENZYMOLOGY AND INHIBITION OF THE BI-FUNCTIONAL JRNL TITL 2 FOLATE PATHWAY ENZYME HPPK-DHPS FROM THE BIOWARFARE AGENT JRNL TITL 3 FRANCISELLA TULARENSIS. JRNL REF FEBS J. V. 281 4123 2014 JRNL REFN ISSN 1742-464X JRNL PMID 24975935 JRNL DOI 10.1111/FEBS.12896 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH G.SHI,J.BLASZCZYK,X.JI,H.YAN REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: REMARK 1 TITL 3 SYNTHESIS AND BIOCHEMICAL AND CRYSTALLOGRAPHIC STUDIES. REMARK 1 REF J.MED.CHEM. V. 44 1364 2001 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 11311059 REMARK 1 REFERENCE 2 REMARK 1 AUTH G.SHI,G.SHAW,Y.H.LIANG,P.SUBBURAMAN,Y.LI,Y.WU,H.YAN,X.JI REMARK 1 TITL BISUBSTRATE ANALOGUE INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW REMARK 1 TITL 3 DESIGN WITH IMPROVED PROPERTIES. REMARK 1 REF BIOORG.MED.CHEM. V. 20 47 2012 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 22169600 REMARK 1 DOI 10.1016/J.BMC.2011.11.032 REMARK 1 REFERENCE 3 REMARK 1 AUTH G.SHI,G.SHAW,Y.LI,Y.WU,H.YAN,X.JI REMARK 1 TITL BISUBSTRATE ANALOG INHIBITORS OF REMARK 1 TITL 2 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE: NEW REMARK 1 TITL 3 LEAD EXHIBITS A DISTINCT BINDING MODE. REMARK 1 REF BIOORG.MED.CHEM. V. 20 4303 2012 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 22727779 REMARK 1 DOI 10.1016/J.BMC.2012.05.060 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.500 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 43002 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.280 REMARK 3 FREE R VALUE TEST SET COUNT : 979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.1101 - 3.2582 0.99 6720 166 0.1644 0.2092 REMARK 3 2 3.2582 - 2.5867 0.96 6460 150 0.1808 0.2282 REMARK 3 3 2.5867 - 2.2599 0.94 6281 160 0.1913 0.2789 REMARK 3 4 2.2599 - 2.0533 0.93 6217 143 0.2230 0.2748 REMARK 3 5 2.0533 - 1.9062 0.89 5972 127 0.2667 0.3121 REMARK 3 6 1.9062 - 1.7938 0.84 5581 130 0.3284 0.3717 REMARK 3 7 1.7938 - 1.7040 0.72 4792 103 0.3597 0.3843 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 1.10 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.570 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3665 REMARK 3 ANGLE : 1.075 4957 REMARK 3 CHIRALITY : 0.062 560 REMARK 3 PLANARITY : 0.005 636 REMARK 3 DIHEDRAL : 12.519 1444 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PZV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000085427. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43013 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRIES 3UDE AND 1TWS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MONOMETHYL ETHER 2000, NACL, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.21700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 180 REMARK 465 GLN A 181 REMARK 465 SER A 182 REMARK 465 PHE A 183 REMARK 465 LYS A 216 REMARK 465 PRO A 217 REMARK 465 ASP A 218 REMARK 465 ALA A 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 10 16.72 -140.59 REMARK 500 TRP A 94 -10.06 72.90 REMARK 500 GLU A 107 -123.30 50.87 REMARK 500 PHE A 188 31.65 -146.06 REMARK 500 ASP A 190 34.70 -151.77 REMARK 500 CYS A 280 41.46 -80.01 REMARK 500 CYS A 280 42.80 -80.01 REMARK 500 ASP A 391 33.43 -87.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE J1D A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 508 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F7V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ESCHERICHIA COLI HPPK IN COMPLEX WITH REMARK 900 BISUBSTRATE ANALOG INHIBITOR J1D DBREF 4PZV A 1 421 UNP Q5NGA7 Q5NGA7_FRATT 1 421 SEQRES 1 A 421 MET GLN TYR ILE ILE GLY ILE GLY THR ASN ILE GLY PHE SEQRES 2 A 421 THR ILE GLU ASN ILE HIS LEU ALA ILE THR ALA LEU GLU SEQRES 3 A 421 SER GLN GLN ASN ILE ARG ILE ILE ARG LYS ALA SER LEU SEQRES 4 A 421 TYR SER SER LYS ALA VAL LEU LYS GLU ASP ALA PRO LYS SEQRES 5 A 421 GLU TRP ASP ILE ARG PHE LEU ASN THR ALA VAL LYS ILE SEQRES 6 A 421 SER SER SER LEU LYS PRO ASP GLU LEU LEU VAL LEU LEU SEQRES 7 A 421 LYS ASP ILE GLU LEU LYS ILE GLY ARG ASP LEU ASN ALA SEQRES 8 A 421 PRO ALA TRP SER PRO ARG VAL ILE ASP LEU ASP ILE LEU SEQRES 9 A 421 ALA ALA GLU ASP LEU ILE LEU GLU THR ASP LYS LEU THR SEQRES 10 A 421 ILE PRO HIS LYS GLU LEU ILE ASN ARG SER PHE ALA LEU SEQRES 11 A 421 ALA PRO LEU LEU GLU LEU SER LYS GLY TRP HIS HIS PRO SEQRES 12 A 421 LYS TYR VAL GLU TRP ASP LEU ASN ILE ARG LEU LYS GLU SEQRES 13 A 421 LEU GLY GLU ILE VAL LYS LEU LYS GLN THR LEU ALA ASN SEQRES 14 A 421 THR ILE ARG MET GLY ILE VAL ASN LEU SER ASN GLN SER SEQRES 15 A 421 PHE SER ASP GLY ASN PHE ASP ASP ASN GLN ARG LYS LEU SEQRES 16 A 421 ASN LEU ASP GLU LEU ILE GLN SER GLY ALA GLU ILE ILE SEQRES 17 A 421 ASP ILE GLY ALA GLU SER THR LYS PRO ASP ALA LYS PRO SEQRES 18 A 421 ILE SER ILE GLU GLU GLU PHE ASN LYS LEU ASP GLU PHE SEQRES 19 A 421 LEU GLU TYR PHE LYS SER GLN LEU ALA ASN LEU ILE TYR SEQRES 20 A 421 LYS PRO LEU VAL SER ILE ASP THR ARG LYS LEU GLU VAL SEQRES 21 A 421 MET GLN LYS ILE LEU ALA LYS HIS HIS ASP ILE ILE TRP SEQRES 22 A 421 MET ILE ASN ASP VAL GLU CYS ASN ASN ILE GLU GLN LYS SEQRES 23 A 421 ALA GLN LEU ILE ALA LYS TYR ASN LYS LYS TYR VAL ILE SEQRES 24 A 421 ILE HIS ASN LEU GLY ILE THR ASP ARG ASN GLN TYR LEU SEQRES 25 A 421 ASP LYS GLU ASN ALA ILE ASP ASN VAL CYS ASP TYR ILE SEQRES 26 A 421 GLU GLN LYS LYS GLN ILE LEU LEU LYS HIS GLY ILE ALA SEQRES 27 A 421 GLN GLN ASN ILE TYR PHE ASP ILE GLY PHE GLY PHE GLY SEQRES 28 A 421 LYS LYS SER ASP THR ALA ARG TYR LEU LEU GLU ASN ILE SEQRES 29 A 421 ILE GLU ILE LYS ARG ARG LEU GLU LEU LYS ALA LEU VAL SEQRES 30 A 421 GLY HIS SER ARG LYS PRO SER VAL LEU GLY LEU ALA LYS SEQRES 31 A 421 ASP SER ASN LEU ALA THR LEU ASP ARG ALA THR ARG GLU SEQRES 32 A 421 LEU SER ARG LYS LEU GLU LYS LEU ASP ILE ASP ILE ILE SEQRES 33 A 421 ARG VAL HIS LYS ILE HET J1D A 501 44 HET EDO A 502 4 HET EDO A 503 8 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 8 HET EDO A 507 4 HET EDO A 508 4 HETNAM J1D 5'-{[2-({N-[(2-AMINO-7,7-DIMETHYL-4-OXO-3,4,7,8- HETNAM 2 J1D TETRAHYDROPTERIDIN-6-YL)CARBONYL]GLYCYL}AMINO) HETNAM 3 J1D ETHYL]SULFONYL}-5'-DEOXYADENOSINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 J1D C23 H30 N12 O8 S FORMUL 3 EDO 7(C2 H6 O2) FORMUL 10 HOH *430(H2 O) HELIX 1 1 PHE A 13 SER A 27 1 15 HELIX 2 2 PRO A 51 ASP A 55 5 5 HELIX 3 3 LYS A 70 GLY A 86 1 17 HELIX 4 4 GLU A 122 ASN A 125 5 4 HELIX 5 5 ARG A 126 SER A 137 1 12 HELIX 6 6 ASP A 149 GLY A 158 1 10 HELIX 7 7 ASN A 191 GLY A 204 1 14 HELIX 8 8 SER A 223 LEU A 242 1 20 HELIX 9 9 ALA A 243 LEU A 245 5 3 HELIX 10 10 LYS A 257 HIS A 269 1 13 HELIX 11 11 ASP A 270 ILE A 272 5 3 HELIX 12 12 ASN A 282 ASN A 294 1 13 HELIX 13 13 ASP A 307 TYR A 311 5 5 HELIX 14 14 ASN A 316 LYS A 334 1 19 HELIX 15 15 ALA A 338 GLN A 340 5 3 HELIX 16 16 LYS A 353 ASN A 363 1 11 HELIX 17 17 ASN A 363 GLU A 372 1 10 HELIX 18 18 LYS A 382 GLY A 387 1 6 HELIX 19 19 ASN A 393 ASP A 412 1 20 SHEET 1 A 4 ILE A 31 LYS A 36 0 SHEET 2 A 4 PHE A 58 SER A 67 -1 O SER A 66 N ARG A 32 SHEET 3 A 4 GLN A 2 THR A 9 -1 N ILE A 7 O THR A 61 SHEET 4 A 4 ASP A 100 ALA A 105 -1 O ALA A 105 N ILE A 4 SHEET 1 B 4 ILE A 31 LYS A 36 0 SHEET 2 B 4 PHE A 58 SER A 67 -1 O SER A 66 N ARG A 32 SHEET 3 B 4 TYR A 40 SER A 42 -1 N SER A 42 O PHE A 58 SHEET 4 B 4 VAL A 161 LYS A 162 -1 O VAL A 161 N SER A 41 SHEET 1 C 2 LEU A 111 GLU A 112 0 SHEET 2 C 2 THR A 117 ILE A 118 -1 O ILE A 118 N LEU A 111 SHEET 1 D 9 ILE A 171 ASN A 177 0 SHEET 2 D 9 ILE A 207 GLY A 211 1 O ASP A 209 N GLY A 174 SHEET 3 D 9 LEU A 250 THR A 255 1 O ASP A 254 N ILE A 210 SHEET 4 D 9 MET A 274 ASP A 277 1 O ASN A 276 N ILE A 253 SHEET 5 D 9 LYS A 296 ILE A 300 1 O LYS A 296 N ILE A 275 SHEET 6 D 9 ILE A 342 ASP A 345 1 O TYR A 343 N ILE A 299 SHEET 7 D 9 LYS A 374 VAL A 377 1 O LEU A 376 N PHE A 344 SHEET 8 D 9 ILE A 415 VAL A 418 1 O ILE A 415 N VAL A 377 SHEET 9 D 9 ILE A 171 ASN A 177 1 N MET A 173 O ILE A 416 CISPEP 1 ILE A 118 PRO A 119 0 -2.94 SITE 1 AC1 22 SER A 42 LYS A 43 VAL A 45 PHE A 58 SITE 2 AC1 22 ASN A 60 LEU A 75 LYS A 79 ARG A 87 SITE 3 AC1 22 TRP A 94 ARG A 97 ASP A 100 ASP A 102 SITE 4 AC1 22 ILE A 103 LYS A 115 LEU A 116 THR A 117 SITE 5 AC1 22 PHE A 128 HOH A 693 HOH A 707 HOH A 767 SITE 6 AC1 22 HOH A 825 HOH A 861 SITE 1 AC2 6 TYR A 145 ASN A 316 ASN A 320 HOH A 659 SITE 2 AC2 6 HOH A 709 HOH A 718 SITE 1 AC3 6 ASN A 177 THR A 215 ARG A 417 HIS A 419 SITE 2 AC3 6 HOH A 763 HOH A 774 SITE 1 AC4 6 GLN A 2 ILE A 4 LYS A 64 GLU A 107 SITE 2 AC4 6 SER A 137 TRP A 140 SITE 1 AC5 2 LEU A 77 LYS A 84 SITE 1 AC6 4 VAL A 161 LYS A 162 LYS A 164 GLN A 202 SITE 1 AC7 3 ASP A 323 GLU A 326 ARG A 370 SITE 1 AC8 7 LYS A 138 TRP A 140 HIS A 141 TRP A 148 SITE 2 AC8 7 ASP A 149 LEU A 150 ASN A 151 CRYST1 42.945 74.434 69.758 90.00 93.20 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023286 0.000000 0.001302 0.00000 SCALE2 0.000000 0.013435 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014358 0.00000